ROBUST: First report of phase III randomized study of lenalidomide/R‐CHOP (R2‐CHOP) vs placebo/R‐CHOP in previously untreated ABC‐type diffuse large B‐cell lymphoma
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 36-37
10.1002/hon.5_2629